SAILIFE logo

Sai Life Sciences Limited Stock Price

NSEI:SAILIFE Community·₹312.1b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author

SAILIFE Share Price Performance

₹1,471.60
546.85 (59.13%)
₹1,369.17
Fair Value
₹1,471.60
546.85 (59.13%)
7.5% overvalued intrinsic discount
₹1,369.17
Fair Value
Price ₹1,471.60
AnalystConsensusTarget ₹1,369.17

SAILIFE Community Narratives

·
Fair Value ₹1.37k 7.5% overvalued intrinsic discount

Global Supply Chain Rebalancing Will Support Long Term Demand For Indian CRDMO Capacity

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative

Trending Discussion

No trending discussion available.

Updated Narratives

SAILIFE logo

SAILIFE: Upcoming Board Review And Updated Assumptions Will Shape Measured Outlook

Fair Value: ₹1.37k 7.5% overvalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

0 Risks
2 Rewards

Sai Life Sciences Limited Key Details

₹22.5b

Revenue

₹5.7b

Cost of Revenue

₹16.8b

Gross Profit

₹13.1b

Other Expenses

₹3.6b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
17.05
74.46%
16.07%
11.6%
View Full Analysis

About SAILIFE

Founded
1999
Employees
3401
CEO
Krishnam Kanumuri
WebsiteView website
www.sailife.com

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.

Recent SAILIFE News & Updates

Narrative Update Aug 10

SAILIFE: Upcoming Board Review And Updated Assumptions Will Shape Measured Outlook

Analysts have lifted their price target on Sai Life Sciences from ₹1,275 to about ₹1,369, citing updated assumptions around revenue growth, discount rate, profit margin and future P/E that feed into their fair value models. What’s in the News for Sai Life Sciences Sai Life Sciences has scheduled a board meeting for August 6, 2026.

Recent updates

No updates